NCT00768690 - A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

February 28, 2009

Conditions

HCV Infection

Interventions

DRUG

ABT-333

Capsule, or powder drug substance from the capsule powder mixed in an alternate vehicle. For additional information refer to arm description.

DRUG

ketoconazole

Tablet, see arms for intervention description

DRUG

placebo

Capsule or powder drug substance from the capsule powder mixed in an alternative vehicle. For additional information refer to arm description.

Trial Locations (1)

Site Reference ID/Investigator# 12701, Waukegan